Issues related to 340b
2026 · 2nd Quarter (Apr 1 - June 30)
INCYTE CORPORATION
Filed by AVENUE SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Client
- INCYTE CORPORATION
- Filing UUID
- 96352bc1-7ed6-40a7-b8c2-2f4f9bdbe874
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.